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CHAPTER - 1 
INTRODUCTION 
 
HERBAL MEDICINE
 [1-3] 
 Ever since the birth of mankind there has been a relationship between disease 
and plants. There is no record that people in prehistoric times used synthetic 
medicines for their ailments. But they tried to make use of the things, which were 
easily available .i.e the plants and animals. They started using plants and found that 
majority of plants were suitable as food, where as other were either poisons or 
medicinally useful. By their experience this knowledge of herbal remedies was 
transferred to generation as folk medicine. So, the history of herbal medicine as old as 
human history. 
 Plants have been used for medicinal purpose long before and recorded in the 
history. For example ancient Chinese and Egyptian papyrus writing describe 
medicinal plants and their uses. Indigenous culture (eg: African and Native American) 
used traditional medicinal systems eg: ayurvedic and traditional Chinese medicine in 
which herbal therapies were used systematically. Scientists found that people in 
different parts of the globe tended to use the same or similar plants for the same 
purpose. 
 In the early 19
th
 century when method of chemical analysis first become 
available scientists started extracting and modifying the active ingredients from 
plants. Later chemists began making their own version of plant compounds, beginning 
the transition from raw herbs to synthetic pharmaceuticals. Over time, the use of 
herbal medicines declined in favour of pharmaceuticals. 
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 Recently the WHO estimated that 80% of people worldwide rely on herbal 
medicine for some aspect of their primary healthcare. In the last twenty years in the 
United States, increasing public dissatisfaction with the cost of prescription 
medications combined with an interest in returning to natural or organic remedies has 
led to an increase in the use of herbal medicines. In Germany roughly 600 to 700 
plant based medicines are available and are prescribed by approximately 70% of 
German physicians. 
 “The lord has created medicines out of the earth and he that is wise will not 
abhor them” 
The WHO defines 4 types of herbal medicines: 
 Raw herbs 
 Herbal material –plant juice, gums, oils, resins, dry powders. 
 Herbal preparations – extracts and tincture of herbal material 
produced by biological, chemical method such as extraction, 
fractionation, purification and concentration.-The basis for finished 
herbal products. 
 Finished herbal products. 
NEUROPATHY 
[4] 
A classical term for any disorder affecting any segments of the nervous 
system.
 
NEUROPATHIC PAIN 
[5] 
 Neuropathy is a collection of disorders that occurs when nerves of the 
peripheral nervous system (the part of the nervous system outside of the brain and 
spinal cord) are damaged. The condition is generally referred to as peripheral 
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neuropathy and it is most commonly due to damage of nerve axons. Neuropathy 
usually causes pain and numbness in the hands and feet. It can result from traumatic 
injuries, infections, metabolic disorders and exposure to toxins. 
Neuropathy can affect nerves that control muscle movement (motor nerves) 
and those that detect sensations such as coldness or pain (sensory nerves).In some 
cases of autonomic neuropathy-it can affect internal organs, such as the heart, blood 
vessels, bladder or intestines. Pain from peripheral neuropathy is often described as a 
tingling or burning sensation. There is no specific length of time that the pain exists, 
but symptoms often improve with time – especially if the neuropathy has an 
underlying condition that can be cured. The condition is often associated with poor 
nutrition. A number of diseases and pressure or trauma but many cases have no 
known reason and other wise called as idiopathic neuropathy. 
CLASSIFICATION OF NEUROPATHY 
[6] 
  Peripheral neuropathy can be broadly classified into the following categories: 
 Mononeuropathy – involvement of a single nerve. Examples include carpal 
tunnel syndrome,ulnar nerve palsy,radial nerve palsy and peroneal nerve 
palsy. 
 Multiple mono neuropathy – two or more nerves individually affected. 
 Polyneuropathy – generalized involvement of peripheral nerves. Examples 
include  diabetic neuropathy and Guillain – Barre syndrome. 
Neuropathy may also be categorized based on functional classification 
(motor,sensory,autonomic or mixed)or the type of onset (acute – hours or days, sub-
acute – weeks or months or chronic – months or years). The most common form of 
neuropathy is (symmetrical) peripheral polyneuropathy, which mainly affect the feet 
and legs on both sides of the body. 
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CAUSES OF NEUROPATHY 
[7,8] 
About 30% of neuropathy cases are considered idiopathic, which means they 
are of unknown cause. Another 30% of neuropathic are due to diabetic. In fact, 
about 50% of people with diabetic are susceptible to some type of neuropathy. 
The remaining cases of neuropathy are called as acquired neuropathies and these 
diseases have several possible causes including 
 Trauma or pressure on nerves, often from repetitive motion such as typing 
on a keyboard. 
 Nutritional problems and vitamins deficiencies, often from a lack of  B  
vitamins. 
 Alcoholism, often through poor dietary habits and vitamins deficiencies. 
 Autoimmune diseases, such as lupus, rheumatoid arthritis and GulianBarre 
syndrome. 
 Tumors, which often press up against nerves. 
 Other disease and infections, as kidney disease,liver disease,lymph 
disease, HIV/AIDS or hypothyroidism. 
 Inherited disorders (hereditary neuropathies)such as Charcot – Marie – 
Tooth disease and amyloid polyneuropathy. 
 Poison exposure from toxins such as heavy metals and certain medications 
and drug induced neuropathic pain as a result of cancer treatment. 
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FIG 1 : Commom causes of neuropathic pain 
 
ANIMAL MODELS OF NEUROPATHIC PAIN
 [9]
 
Chemical induced model 
a, Acrylamide induced neuropathy. 
Disease induced model 
 a, Diabetic induced model 
 b, cancer pain model 
3.peripheral nerve injury model 
a, Chronic constriction injury model 
 b, Complete sciatic nerve transition model 
 c, Partial sciatic nerve ligation model 
d, Spinal nerve ligation model 
e, Tibal and sural nerve transition 
f, Common peroneal nerve ligation model 
4 .Drug induced model 
 a, Vincristine induced model 
 b, Anti HIV drug induced model 
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5.Micellaneous model 
 a, Chronic ethanol consumption/withdrawal induced neuropathy 
 b ,Pyridoxine deficiency induced neuropathy 
HERBS USED TO CURE NEUROPATHY
 [10] 
 Neuropathy is a term that refers to problems associated with the peripheral 
nervous system and it may cause muscle weakness,spasms,cramps and pain. These 
symptoms can be easily triggered by outside stimuli and they may occur over again 
unless treated. There are some herbal remedies that cure or treat these conditions 
without the sideeffects of allopathic medicine. 
 Hypericumper foratum. 
 Polygonummultiflorum. 
 Levisticum officinale. 
 Filipendula ulmaria. 
FIG 2 : Estimated  prevalence of neuropathic pain in USA 
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INFLAMMATION 
[11]
 
 Inflammation is part of the complex biological response of vascular tissues to 
harmful stimuli, such as pathogens damaged the cells. The classical signs of 
inflammation are : 
 Pain 
 Heat 
 Redness 
 Swelling 
 Loss of function 
Inflammation can be classified as 
1. Acute: 
Characterized by local vasodilatation and increased capillary 
permeability. 
2. Sub- acute : 
Characterized by infiltration of leukocytes and phagocytic cells. 
3. Chronic : 
Tissue degeneration and fibrosis. 
CAUSES OF INFLAMMATION  
 The main reasons of inflammation are burns, ionizing radiation, toxins, stress, 
trauma, and alcohol.    
FIG 3: Causes of inflammation 
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ANIMAL MODELS FOR INFLAMMATION
 [12]
 
I) Acute and sub-acute inflammation: 
 1, Paw edema 
 2, Croton oil ear edema  
 3, Pleurisy test 
 4, Ultra violet erythema  
 5, Oxazolone induced ear edema 
 6, Granuloma pouch technique 
 7, Vascular permeability 
II) Proliferative phase: 
 Cotton pellet granuloma 
 Adjuvant arthritis 
 Sponge implantation technique 
 Glass rod granuloma  
HERBS USED TO CURE INFLAMMATION
[13] 
 Ocimum sanctum (holy basil). 
 Curcuma longa (turmeric). 
 Boswellia serrate (indianolibanum). 
 Ginger. 
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CHAPTER 2 
LITERATURE REVIEW 
ETHNO-MEDICINAL INFORMATION
 [14]
 
 The plant is extensively used as an anti- inflammatory. 
 It is used in folk medicine. 
 The plant extracts are used as medicine to treat fatigue and venereal disease. 
 The leaf is used for skin infection, inflammation and laxative. 
 The decoction of the roots and leaves are used in rheumatism, gout and 
gonorrhea. 
PHYTOCHEMISTRY 
Pareda mirinda  et al.,(2005) have studied  the hexane soluble extract of aerial 
parts of the drug Ipomoea pes-caprae  (morning glory) by preparative scale HPLC 
and reported six lipophilic glycosides.
[15]
 
 Martinez et al.,(2008) have studied the hexane soluble extracts from the leaf of 
Ipomoea pes-caprae by preparative scale HPLC and reported the resin glycosides.
[16]
 
Deepak venkataraman et al.,(2013) have studied the phytochemistry of 
ethanolic extracts of Ipomoea pes-caprae. The study revealed the presence of 
alkaloids, carbohydrate, flavonoid, tannin, glycosides, terpenoids and sterols.
 [17]
 
PHARMACOLOGY 
Pongprayoon et al., (1991) have studied the effect of extract of Ipomoea pes-
caprae in the treatment of dermatitis caused by poisonous jelly Fish toxins. The 
extract also exhibited significant antispasmodic activity in isolated guinea pig ileum 
and anti-inflammatory activity in carrageen an induced in rat paw edema.
[18]
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Philippi et al.,(2010) have reported immunostimulatory activity from 
Calophyllum brasilliense, Ipomoea pes-caprae and Mutayaba elaeagnoides by human 
peripheral blood mononuclear cell proliferation. The result reveals that significant 
immunostimulatory activity of these plants.
 [19]
 
Deepak venkataraman et al.,(2013) have showed anti-inflammatory activity of 
ethanolic extract from aerial parts of Ipomoea pes-caprae using cotton pellet induced 
granuloma model.
[20]
 
Umamaheshwari et al.,(2012) have studied the antioxidant and radical 
scavenging activity of ethanolic extract of Ipomoea pes-caprae.
[21]
 
Deepak venktaraman et al.,(2013) have reported ethanolic extracts of Ipomoea 
pes-caprae was showed antiulcer effect(200 and 400 mg/kg) in aspirin and pyloric 
ligation induced gastric ulcer models in wistar rats. Ranitidine used as a standard.
[22]
 
Ramanathan et al.,(2011) have reported the in vitro antifungal activity 
ethanolic extract of Ipomoea pes-caprae by agar diffusion method.
[23]
 
OTHER SPECIES 
PHARMACOGNOSY 
Martins et al.,(2012) have studied the leaf anatomy and histochemistry for 
Ipomoea    asarifolia.
 [24]
 
 Rajendran et al.,(2008) have  studied  the pharmacognostical Identification of 
stem and root  of Ipomoea quamoclit.
[25]
 
 Siddiqi et al.,(1990) have evaluated  the botanical characters of Ipomoea 
hederarea.
[26] 
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PHYTOCHEMISTRY 
Ono et al.,(2010) have discussed the resin glycosides from the leaves and stem 
of Ipomoea digitata. The leaves and stem of the ipomoea gave six organic acids.
[27]
 
 Nair et al.,(2010) have reported the chemical and nutrient analysis of the weed 
Ipomoea carne..The study revealed the presence of flavonoids, tannins, alkaloids, 
amino acid, phenolicacid, sugar and saponins.
[28]
 
 Yin et al.,(2009) have reported the three new pentasaccharide resin glycosides 
from the root of Ipomoea batatas.
 [29]
 
Yahara et al.,(2002) have isolated the phenolic compounds from the 
methanolic extract of dried leaves of  Ipomoea batatas and these compounds were 
identified by spectral studies.
[30]
 
Singh Gupta et al.,(1995) have isolated a water soluble  seed gum 
polysaccharide containing D-galactose and D-mannose as sugars from  Ipomoea pes-
tigridis and its structural elucidation has also been described.
 [31]
 
Ono et al.,(1991) have isolated the ether soluble resin Glycosides, operculins 
from the roots of Ipomoea operculata. They were characterized on the basis of 
chemical and spectral analysis.
[32]
 
Wilkinson et al.,(1987) have isolated the seed alkaloids from Ipomoea 
coccinea, Ipomoea wrightii and these alkaloids were quantified by spectrophotometry 
as ergonovine maleate equivalents.
[33]
 
Harrison et al.,(1986) have examined the four new fatty acid glycosides from 
Ipomoea dichroa. They were identified as dichrosides A, B, C and D besides 
friedelin, stearic acid, β-sitosterol and its glycosides. [34] 
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Schneider et al.,(1984) have isolated nine new sesquiterpenes from the root 
Ipomoea batatas and their structure were also determined.
[35]
 
PHARMACOLOGY; 
Haw et al.,(2012) have reported  the hypouricemic effect  of anthocyanin 
extracts of Ipomoea batatas on potassium oxolate induced hyperuricemic in mice
 [36]
. 
            Leon Rivera et al.,(2011) have demonstrated the sedative, Vasorelaxant, 
cytotoxic effect of convolvulin  from the root extract of Ipomoea tyrianthina
[37]
. 
Chimkode et al.,(2010) have reported the wound healing activity  from the 
tuberous root extract of  Ipomoea batata in vivo model 
[38].
 
Lin et al.,(2009) have  studied the cytotoxic  activity  of  the ethanolic extract   
from Ipomoea cairica
[39]
. 
Herrera-Ruiz et al.,(2008) have reported the central  nervous system 
depressant activity  of  ethylacetate extract from Ipomoea stans root .The 
administration of this extract produced an anxiolytic effect in mice(20 -40 mg/kg)
 [40]
. 
 DattaChoudry et al.,(2007) have studied the chemical characterization  and 
antifungal and CNS  depressant activity of Ipomoea aquatica. The methanolic extract 
of Ipomoea aquatic showed the antifungal activity against candida albicans(1.6cm) 
and for CNS depressant activity in mice which was almost equal to the effect of 
standard drug
[41]
. 
Ferreira et al.,(2006) have evaluated anti nociceptive effect of Ipomoea 
cairica. The ethanolic extract (100,300,1000 and 3000 mg/kg; p.o.) of this plant 
induced dose dependent reduction of response in the formalin test inflammatory phase 
in mice model. The same dose range did not modify neurogenic pain in formalin test 
and tail flick reflex latency in carrageenan induced paw edema and rota –rod test[42]. 
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Leon et al.,(2005) have estimated pentasaccharide glycosides from the root of 
Ipomoea murucoides. These constituents were evaluated for cytotoxicity against of 
cancer cell lines
[43]
. 
Yoshimoto et al.,(2004) have estimated the phenolic composition and radical 
scavenging activity of sweet potato Ipomoea batatas treated with koji [aspergillus 
awamori and cellulose (cellulosinT2)
 [44]
. 
 Haueza et al.,(2003) have reported the immunomodulatory activity of 
Ipomoea carnea on peritoneal cells of rats model. The experimental model suggested 
that low doses of Ipomoea carnea induced enhanced phagocytosis activity and 
hydrogen peroxide production by macrophages 
[45]
 
Mastui et al.,(2002) have performed anti-hyperglycemic  effect  of diacylated 
anthocyanin isolated from Ipomoea batatas. They suggested that anthocyanin possess 
alpha glucosidase inhibitory activity after a single oral administration in 8weeks old 
male rats
[46]
. 
Kusano et al.,(2001) have reported isolation of anti-diabetic components from 
Ipomoea batatas
[47].
 
 Navarro-Ruiz et al.,(1996) have demonstrated the anti-convulsant effect of 
aqueous hydro-alcoholic and chloroform extracts from roots  of Ipomoea stans. 
Maximal electroshock seizure inducing test(MES) and subcutaneously injected 
metrazole (METSC)were the premental epilepsy model used and maximum activity 
was seen with aqueous extract
[48]
. 
Reynolds et al.,(1995) have isolated and characterized the cytotoxic and 
antibacterial tetrasaccharide glycoside from Ipomoea stans. These compounds have 
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pronounced cytotoxicity towards three human tumor cell lines as well as specific 
antibiotic activity against two bacterial strains
 [49]
.  
Reza et al.,(1994) have studied the antibacterial activity of the chloroform 
extract of different parts of Ipomoea fistulosa against all the strains of shigella and the 
gram positive bacteria namely Bacillus megaterium and Bacillus polymyxa. The 
extract exhibited significant anti-bacterial activity.
[50]
 
Dasilvo Filho et al.,(1986) have described the isolation of four new 
antimicrobial glycosides from Ipomoea bahensis. They showed significant activity 
against sarcoma 180 in mice model. 
[51]
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CHAPTER - 3 
AIM AND SCOPE 
Ipomoea pes-caprae.Linn.R.Br. (convolvulaceae) is a creeper and twinning, 
glabrous herb. The leaves often broad than long, fleshy, orbicular, obtuse emarginated 
and bilobed. The plant is very common and this abundant weed was distributed 
throughout India in the sandy shoves and sandy river banks. It also grows near the sea 
and other sandy areas throughout India. 
[52]
 
 The ethno-medicinal information revealed that almost all parts of the plant are 
employed in various indigenous system of medicine to treat several diseases; 
 Ipomoea pes- caprae is used for the treatment of rheumatoid arthritis. 
 The leaves are used in stomachic and nervine tonic. 
 The plant is used for insulinogenic and hypoglycemic activity as well as 
antinociceptive properties.   
 Ipomoea pes-caprae is often used by fisherman to treat jelly fish sting. 
 The roots have diuretic properties and used to treat bladder problems, 
stranguary, dysuria and oedema. 
According to the literature survey, this plant has not been reported for painful 
neuropathy though ethno-medicinal information indicates that it has been used for the 
treatment of nervous disorders. 
So, the present work has been designed to carry out the following works on 
the leaves of Ipomoea pes-caprae. 
1. It was planned to carry out the detailed pharmacognostical studies on this 
leaves of this plant. 
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2. Preliminary phytochemical studies were carried out for the crude drug as well 
as extracts of this plant in order to confirm the presence of phytoconstituents  like  
flavonoids, tannins, glycosides, carbohydrates and saponins. 
3. To estimate the total phenolic, flavonoid and tannin content in the extracts of 
this plant 
4. Phytochemical evaluation including identification and characterization of the 
active principles by HPLC. 
5. It was planned to evaluate the extract of this plant for the following 
pharmacological studies. 
A. Determination of antioxidant potential of extracts by, 
 Hydrogen peroxide scavenging activity. 
 DPPH (2,2,diphenyl-2-picryl hydrazyl) assay 
 Phosphomolybdenum method 
 Reducing power assay  
 
B. Pharmacological evaluation of Ipomoea pes-caprae against vincristine 
induced neuropathic pain in rats. 
C. In vitro anti-inflammatory activity of the plant extract by Human red blood 
corpuscles membrane stabilization model (HRBM). 
    
  
 
 
 
PLANT PROFILE 
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CHAPTER – 4 
PLANT  PROFILE 
Ipomoea pes-caprae Linn.R.Br. is a creeper and twinning, glabrous herb 
belonging to the family convolvulaceae. 
SYNONYM
[53]
 
  Ipomoea biloba,beach morning glory,railroad vine. 
SYSTEMATIC POSITION 
Kingdom      - planta 
Subkingdom   -    tracheophyta 
Super division              -           Spermatophyta 
Division   - Magnoliophyta 
Class    - Magnoliopsida 
Sub class   - Asteridae 
Order    - Solanales 
Family                          - Convolvulaceae 
Genus    - Ipomoea 
Species   -  pes-caprae 
VERNACULAR NAMES 
Sanskrit    - Vriddadaru 
Hindi    - Dopatilata 
Bengali   - chagalkhuri 
Tamil    - Adambuvalli,adappankodi 
Malayalam        -   Chuvannaadambu 
English   - Goat’s foot creeper 
Gujarathi   - Ravarapatri 
Telugu               -    Balabandatige 
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GEOGRAPHICAL DISTRIBUTION 
[54]
 
Ipomoea pes-caprae is a pan tropical vine. It is distributed South Atlantic, 
Gulf coasts, Texas, Mexico and throughout peninsular Florida. It is established 
worldwide on many tropical beaches including those of Australia and the Caribbean. 
HABITAT OF PLANT 
Rail road vine grows rapidly, but unevenly. Its common name can be 
attributed its ability to send out “tracks” of stolons more than 100 feet long. Stolons 
are similar to stems except they produce adventitious roots at the nodes and run 
horizontally rather than vertically. Taproots are deep, sometimes penetrating 3 feet 
into the soil. This ground-hugger usually grows to a height of more than 16 inches tall 
but, can form a dense groundcover as much as 30 feet across. 
DESCRIPTION OF PLANT  
LEAVES 
A creeper and twinning glabrous herb. Leaves are broader than long. It is 
fleshy, orbicular, obtuse, emarginated or bilobed and prominently nerved. 
STEM 
The new stem is up to 0.5 inches in diameter. 
FRUIT 
 Fruit is globes about 13-20 mm diameter. Calyx lobe is persistent at the base. 
Pedicels are about 50 mm long. 
FLOWER 
 Auxiliary, funnel shaped flowers are pink to lavender purple colour. It is about 
2 inches long. Corollas are 3-6 cm in length. 
SEED  
 Seeds are black. It bears trigonous- globose shape. 
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CHAPTER 5 
MATERIALS AND METHODS 
PART I – PHRAMACOGNOSTICAL STUDIES 
SECTION- A 
MACROSCOPY OF THE LEAVES
 [55]
 
Organoleptic characters such as colour, odour, texture, shape, size, apex, 
venation and arrangement of the leaves were studied for this plant. 
The photographic representation of the macroscopic features are presented in 
Fig 4 – 10. 
 
SECTION - B 
MICROSCOPICAL STUDIES OF THE LEAVES 
[ 56]
 
Collection of plant material 
Plants were collected from Ramnad and identified by taxonomist. 
Specimen collection  
Petiole and leaf were fixed in FAA solution (70% ethyl alcohol, formalin and 
acetic acid in the ratio of 90 mL: 5 mL: 5 mL).  The materials were kept in the fluid 
for three days, after which they were washed in water and dehydrated with tertiary 
butyl alcohol.  Paraffin wax was filtered and the specimens were embedded in wax for 
sectioning
[57-61]
. 
Sectioning 
Transverse sections of petiole and leaf were taken using microtome and 
stained with toluidine blue. All sides, after staining in toluidine blue were dehydrated 
by employing graded series of ethyl alcohol (70 %, 90%, 100% alcohol) and xylol-
alcohol (50-50) and passed through xylol and mounted in DPX mountant
[62-64]
. 
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 Clearing of leaves 
Clearing of leaves for studying stomatal number and stomatal index was done 
by using 5% sodium hydroxide with chlorinated soda solution supplemented with 
gentle heat.  Quantitative microscopy of leaves was carried out was studied as per the 
procedure given standard procedure. Photomicrographs were taken with the help of 
Nikon Eclipse E200 Microscope. Powder microscopy of the leaf powder was also 
studied 
[64-67]
. 
SECTION - C 
QUANTITATIVE MICROSCOPY 
Various quantitative microscopical parameters were studied for the leaves of 
Ipomoea pes-caprae.  
STOMATAL NUMBER AND STOMATAL INDEX
[68]
 
Stomatal number 
The average number of stomata present in 1 square millimeter area of   each 
surface of a leaf epidermis is termed as stomata lnumber. 
Stomatal index  
The stomatal index is the percentage of the number of stomata formed by the 
total number of epidermal cells including stomata, each stoma being counted as one 
cell. 
Determination of stomatal number and stomatal index 
To study the stomatal morphology (type of stomata), stomatal number and 
stomatal index of leaf, the leaf was subjected to epidermal peeling by partial 
maceration employing the Jeffrey’s maceration fluid. 
A fragment was transferred in to microscopic slide and the mount of lower and 
upper epidermis was prepared with a small drop of glycerol solution at one side of the 
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cover slip to prevent the slide from drying. The slide was examined under 45X 
objective and 10X eye piece to which a microscopical apparatus was attached. Circle 
(O) like mark was marked on the drawing paper for each stoma. The average number 
of stomata/square mm for each surface of the leaf was calculated and their values are 
tabulated in table 1. 
For stomatal index, the glycerin mounted leaf peeling as mentioned above was 
made and circle (O) like mark for each stomata and a cross (X) like mark for each 
epidermal cells was marked on the drawing paper. The stomatal index was calculated 
by using the formula,  
Stomatal index        S.I =
 
   
 ×100 
Where,  
 S = Number of stomata in 1 sq mm area of leaf  
 E = Number of epidermal cells (including trichomes) in the same area of leaf.  
VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER
 [70]
 
The term vein islet is used to denote the minute area of photo synthetic tissue 
encircled by the ultimate division of the conducting strands. The number of vein islets 
per square mm area is called vein- islet number. 
Vein termination number may be defined as the number of vein terminations 
present in one square mm area of the photosynthetic tissue.  
Determination of Vein Islets and Vein Terminations 
The fragment of leaf lamina with an area of not less than 1 sq mm excluding 
the midrib and the margin of the leaf was taken. The fragments of leaf lamina were 
cleared by heating in a test tube containing chloral hydrate solution on a boiling water 
bath until clear. The cleared fragments were stained with safranin solution and a 
temporary mount was prepared with glycerol solution. The stage micrometer placed 
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on the microscopic stage, examined under 10X objective and 10X eye piece and an 
area of 1 sq mm square was drawn. The cleared leaf piece was placed on the 
microscope stage, the vein islets and vein terminals included in the square was drawn. 
The number of vein islets and terminals within the square including those over 
lapping on two adjacent sides and excluding those intersected by others two sides 
were counted. The results obtained in the number of vein islets and terminals in1 sq 
mm were tabulated in table 1. 
PALISADE RATIO
 [71]
 
Palisade ratio is the average number of palisade cells under one epidermal cell. 
It is another important criterion for identifications and evaluations for crude drugs. 
Since it is constant for a plant species which is useful to differentiate the species and 
does not altered based on geographical variation. 
Determination of Palisade Ratio 
Epidermal peeling was done by partial maceration by Jeffery’s maceration 
fluid were prepared. A fragment was transferred into a microscopical slide and the 
mount of upper epidermis was prepared with a small drop of glycerol on one side of 
the cover slip to prevent the preparation from drying. The same was examined under 
45X objective and 10X eye piece. Four adjacent epidermal cells were traced; focusing 
gently downward to bring the palisade cells into view and sufficient palisade cells to 
cover the outlined four epidermal cells were then traced. The palisade cells under the 
epidermal cells were counted and calculate the palisade ratio by using the following 
formula and the results were tabulated in table 1. 
Palisade ratio = Avg. number of palisade cells beneath the 4 epidermal 
cells/4 
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SECTION - D 
POWDER MICROSCOPY AND ANALYSIS 
The behavior of the powder with different chemical reagents was carried out 
as per standard procedure. The observations are presented in fig 15. 
Fluorescence analysis 
[78] 
The fluorescent analysis of the plant extracts of Ipomoea pes-caprae was 
carried out by treating the sample with various reagents and expose them under day 
light and UV light (264 and 366 nm) and the observations are tabulated in table.2. 
SECTION – E 
PHYSICO-CHEMICAL PARAMETERS 
STANDARDIZATION PARAMETERS  
The evaluation of ash values, loss on drying, foreign organic matter and 
extractive values etc. gives a clear idea about the specific characteristics of crude drug 
under examination, besides its macro-morphological or cyto-morphological, 
microscopically nature in both its entire and its powder form. These diagnostic 
features enable the analyst to know the nature and characteristic of crude drugs and 
further evaluation of different parameters indicate their acceptability. The procedures 
recommended in Indian Pharmacopoeia, 1996 and WHO guidelines, 1998 were 
followed to calculate total ash, water-soluble ash, acid-insoluble ash and loss on 
drying. The percentages of extractive values for different solvents were also 
determined for this plant. 
Determination of Volatile Oil  
Volatile oils are characterized by their odor, oil like appearance and also it has 
ability to volatilize at room temperature. Chemically they are mixtures of 
Materials and methods 
 
Department of Pharmacognosy, MMC, Madurai. 24 
 
monoterpenes, sesquiterpenes and their oxygenated derivatives. Volatile oils can be 
estimated by hydro distillation method. 
An accurately weighed 100g of plant material was crushed and introduced in 
to the flask containing distilled water and glycerol until one third of the plant material 
was immersed and few pieces of porcelain bits were added. The flask containing 
liquid was heated until it boils. After 3h, heating was stopped and the collected oil 
was recorded on the graduated receiver tube. Oil content of the plant material was 
calculated in mL/100 g of plant materials.  
Determination of foreign organic matter
[72] 
The part of organ or organs other than those specified in the definition or 
description of the crude drugs is defined as foreign organic matter.  
An accurately weighed 100g of air dried coarse drug and spread out in a thin 
layer. The sample drug was inspected with the unaided eye or with the use of 6X lens 
and the foreign organic matter was separated manually as completely as possible and 
weighed. The percentage of foreign organic matter was calculated with reference to 
the weight of the drug taken. The result is presented in table 3. 
Determination of Moisture Content (Loss on Drying) 
An accurately weighed 10 g of coarsely powdered drug was placed in a tarred 
evaporating dish. Then the dish was dried at 105
o
C for 5 h and weighed. The drying 
and weighing was continued at one hour intervals until the difference between the two 
successive weighing is not more than 0.25 %. The loss on drying was calculated with 
reference to the amount of powder taken. The readings are tabulated in table 3. 
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Determination of Ash values
[73]
  
Ash Content   
 The residue remaining after incineration is the ash content of crude drug, 
which simply represents inorganic salts naturally occurring in the drug or adhering to 
it or deliberately added to it as a form of adulteration. 
Determination of Total Ash 
 An accurately weighed 3 g of air dried coarsely powdered drug was taken in a 
tarred silica crucible and incinerated at a temperature not exceeding 450
o
C, until free 
from carbon then allowed to cool and weighed. The percentage of ash was calculated 
with reference to the air dried drug.   
Determination of Acid Insoluble Ash 
The total ash obtained from the previous procedure was mixed with 25 mL of 
2 M hydrochloric acid and boiled for 5 min in a water bath, and then the insoluble 
matter was collected in an ashless filter paper and washed with hot water, dried and 
ignited for 15 min at a temperature not exceeding 450
o
C, cooled in desiccators and 
weighed. The percentage of acid insoluble ash was calculated with reference to the air 
dried drug.     
Determination of Water Soluble Ash 
The total ash obtained from the previous procedure was mixed with 25 mL of 
water and boiled for 5 min in a water bath, and then the insoluble matter was collected 
in an ashless filter paper and washed with hot water, dried and ignited for 15 min at a 
temperature not exceeding 450
o
C, cooled in desiccators and weighed. The insoluble 
matter was subtracted from the weight of the total ash; the difference in weight 
represents the water soluble ash. The percentage of water soluble ash was calculated 
with reference to the air dried drug. 
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The values in respect of the total ash values, acid insoluble ash, water soluble 
ash and water insoluble ash are tabulated in table 3. 
DETERMINATION OF EXTRACTIVE VALUES 
[74]
 
Determination of ethanol soluble extractive     
 An accurately weighed 5 g of the air dried coarsely powdered drug was 
macerated with 100mL of ethanol in a closed flask for 24 h, shaking frequently during 
the first 6 h and allowed to stand for 18 h. Thereafter filtered rapidly, taking 
precautions against loss of ethanol. Then evaporate 25 mL of the filtrate to dryness in 
a tarred flat bottomed shallow dish dry at 105
o
C and weighed. The percentage of 
ethanol soluble extractive was calculated with reference to the air dried drug. 
Determination of water soluble extractive, hexane soluble extractive and 
petroleum soluble extractive, methanol soluble extractive, chloroform soluble 
extractive and ether soluble extractive values       
 The procedure adopted for ethanol soluble extractive value was followed for 
the determination of water soluble extractive, hexane soluble extractive and petroleum 
soluble extractive, methanol soluble extractive, chloroform soluble extractive and 
ether soluble extractive values and the results are presented in table 4 
Determination of Foaming Index
 
 Plant materials contain saponins that can cause persistent foam when an 
aqueous decoction is shaken. The foaming ability of an aqueous decoction of plant 
materials and their extracts is measured in terms of foaming index.  
 An accurately weighed 1 g of the coarse plant material was transferred into a 
500 mL conical flask containing 100 mL of boiling water. The flask was maintained 
at moderate boiling for 30 min. The solution was cooled and filtered into a 100 mL 
volumetric flask and sufficient distilled water was added to dilute to volume. The 
decoction was poured into 10 stoppered test tubes in successive portions of 1 mL, 
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2mL, etc. up to 10 mL, and the volume of the liquid in each tube was adjusted with 
water up to 10 mL. The tubes were stoppered and shaken in a length wise motion for 
15 sec (two shakes/sec) and allowed to stand for 15 min. The height of foam was 
measured.  If the height of the foam in every tube was less than 1cm the foaming 
index was less than 100. If a height of foam of 1 cm was measured in any test tube, 
the volume of the plant material decoction in this tube (a) was used to determine the 
index. If this tube was first or second tube in a series, an intermediate dilution was 
prepared in a similar manner to obtain a more precise result. 
 If the height of the foam was more than 1cm in every tube, the foaming index 
was over 1000. In this case, the determination was repeated using a new series 
dilution of the decoction in order to obtain a result. The foaming index was calculated 
using the following formula 1000/A where A was the volume in mL of the decoction 
used for preparing the dilution in the tube where foaming to a height of 1 cm was 
observed. The result obtained is presented in table 4. 
 
Determination of Swelling Index
[75] 
 Swelling index is the volume in mL taken up by the swelling of 1 g of plant 
material under specified conditions. Its determination is based on the addition of 
water. Using a glass stoppered measuring cylinder, the material is shaken repeatedly 
for 1 h and then allowed to stand for required period of time. The volume of the 
mixture (in ml) is read. 
 About 1 g of weighed powder was introduced in to a 25 mL glass stoppered 
measuring cylinder, and 25 mL of water was added and the mixture was shaken 
thoroughly every 10min for 1 h and allowed to stand for 3 h at room temperature. The 
volume in mL occupied by the plant material including the sticky mucilage was 
measured. The mean value of the individual determination was calculated related to 1 
gm of plant material and the result is tabulated in table 4. 
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PART - II 
PHYTO CHEMICAL STUDIES 
 Phytochemistry deals with natural product organic chemistry and plant 
biochemistry. It also deals with a variety of secondary metabolites that are produced 
by plants, their chemical structures, biosynthesis, metabolism, natural distribution and 
biological functions. This chapter deals with isolation and identification of 
phytoconstituents of this plant.
[80]
 
Collection and authentication 
The leaves of Ipomoea pes-caprae was collected in and around Ramnad and 
authenticated by taxonomist. The shade dried leaves were powdered and then 
subjected to the following preliminary phytochemical studies.  
SECTION- A 
PRELIMINARY PHYTOCHEMICAL SCREENING 
All the extracts were subjected to qualitative chemical analysis. The various 
chemical tests were performed on the extracts for the identification of sterols, 
terpenoids, flavones, anthraquinones, sugars glycosides, alkaloids, quinones, phenols 
and tannins. The results were tabulated in table 5& 6. 
 1. TEST FOR STEROLS
[81]
 
The powdered leaf was first extracted with petroleum ether and evaporated toa 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
a. SALKOWSKI’S TEST 
  A few drops of concentrated sulphuric acid was added to the above 
solution, shaken well and set aside. The lower chloroform layer of the solution turned 
red in color indicating the presence of sterols. 
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b. LIEBERMANN – BURCHARD’S TEST 
  To the chloroform solution a few drops of acetic anhydride and 1 ml of 
concentrated sulphuric acid were added through the sides of the test tube and set aside 
for a while. At the junction of two layers a brown ring was formed. The upper layer 
turned green indicating the presence of sterols. 
2. TEST FOR CARBOHYDRATES 
a. MOLISCH’S TEST 
  The extract of the powdered leaf was treated with 2-3 drops of 1% 
alcoholic -naphthol and 2ml of concentrated sulphuric acid was added along the 
sides of the test tube. A purple color indicating the presence of carbohydrates. 
b.FEHLING’S TEST 
  The extract of the powdered leaf was treated with Fehling’s solution I 
and II and heated on a boiling water bath for half an hour. Red precipitate was 
obtained indicating the presence of free reducing sugars. 
c .BENEDICT’S TEST: 
 The extract of the powdered leaf was treated with equal volume of 
Benedict’s reagent. A red precipitate was formed indicating the presence of reducing 
sugar. 
3.TEST FOR PROTEINS 
a. MILLON’S TEST  
A small quantity of acidulous – alcoholic extract of the powdered drug 
was heated with Millon’s reagent. White precipitate turned red on heating indicate the 
presence of proteins.  
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b. BIURET TEST 
To one portion of acidulous – alcoholic extract of the powdered drug 
one ml of 10% sodium hydroxide solution and one drop of dilute copper sulphate 
solution were added. Violet color was obtained indicating the presence of proteins. 
4. TEST FOR ALKALOIDS 
About 2 gm of the powdered material was mixed with 1gm of calcium 
hydroxide and 5 mL of water into a smooth paste and set aside for 5 minutes. It was 
then evaporated to dryness in a porcelain dish on a water bath. To this 200 mL of 
chloroform was added, mixed well and refluxed for half an hour on a water bath. 
Then it was filtered and the chloroform was evaporated. To this 5 mL of dilute 
hydrochloric acid was added followed by 2 mL of each of the following reagents. 
a) MAYER’S TEST: 
 A small quantity of the extract was treated with Mayer’s reagent. Cream 
colour precipitate indicates the presence of alkaloids. 
b) DRAGEN DORFF’S TEST: 
 A small quantity of the extract was treated with Dragendorff’s reagent. Orange 
brown precipitate indicates the presence of alkaloids. 
c) WAGNER’S TEST:   
 A small quantity of extract was treated with Wagner’s reagent. Reddish brown 
precipitate indicates the presence of alkaloids.    
d) HAGER’S TEST: 
 A small quantity of extract was treated with Hager’s reagent. Yellow 
precipitate indicates the presence of alkaloids. 
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e) TEST FOR PURINE GROUP (MUREXIDE TEST) 
The residue obtained after the evaporation of chloroform was treated with 
1mL of hydrochloric acid in a porcelain dish and 0.1 gm of Potassium chlorate was 
added and evaporated to dryness on water bath. Then the residue was exposed to the 
vapour of dilute ammonia solution. No purple Color was obtained indicating the 
absence of purine group of alkaloids. 
5. TEST FOR GLYCOSIDES 
a) BORNTRAGER’S TEST 
The powdered leaf was boiled with dilute sulphuric acid, filtered and to the 
filtrate benzene was added and shaken well. The organic layer was separated to which 
ammonia solution was added slowly. Ammoniacal layer showed the pink colour 
indicating the presence of anthraquinone glycosides. 
b) MODIFIED BORNTRAGER’S TEST 
About 0.1 g of the powdered drug was boiled for 2 minutes with dilute 
hydrochloric acid and few drops of ferric chloride solution, filtered while hot and 
cooled. The filtrate was then extracted with benzene and the benzene layer was 
separated. Equal volume of dilute ammonia solution was added to the benzene extract. 
Pink color was observed in ammoniacal layer showing the presence of anthraquinone 
glycosides. 
c) TEST FOR CARDIAC GLYCOSIDES(FOR DEOXYSUGAR) 
i) KELLER KILIANI TEST 
About 1 g of the powdered leaf was boiled with 10 ml of 70 % alcohol for 2 
minutes, cooled and filtered. To the filtrate 10 mL of water and 5 drops of solution of 
lead subacetate were added and filtered, evaporated to dryness. The residue was 
dissolved in 3 mL of glacial acetic acid. To these 2 drops of ferric chloride solution 
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was added. Then 3 mL of concentrated sulphuric acid was added to the sides of the 
test tube carefully and observed. No Reddish brown layer was observed indicating the 
absence of deoxysugars of cardiac glycoside 
d) TEST FOR CYANOGENETIC GLYCOSIDES 
Small quantity of the powder was placed in a stoppered conical flask with just 
sufficient water, to cover it. A sodium picrate paper strip was inserted through the 
stopper so that it was suspended in the flask and it was set aside for 2 hours in a warm 
place. No brick red color was produced on the paper indicating the absence of 
cyanogenetic glycosides. 
6.TEST FOR SAPONINS 
About 0.5g of the powdered drug was boiled gently for 2 minutes with 20 mL 
of water and filtered while hot and allowed to cool. 5 mL of the filtrate was then 
diluted with water and shaken vigorously. Frothing was produced indicating the 
presence of saponins. 
7. TEST FOR TANNINS 
A small quantity of the powdered drug was extracted with water. To the 
aqueous extract few drops of ferric chloride solution was added. Bluish black color 
was produced indicating the presence of tannins. 
8. TEST FOR FLAVONOIDS 
a. SHINODA’S TEST 
A little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were 
added. Boiled  for five minutes. Red colour was obtained indicating the presence of 
flavonoids. 
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b. ALKALI TEST 
To the small quantity of test solution 10% aqueous sodium hydroxide Solution 
was added. Yellow orange color was produced indicating the presence of flavonoids.  
c. ACID TEST 
To the small quantity of test solution, few drops of concentrated sulphuric acid 
were added. Yellow orange colour was obtained indicates the presence of flavonoids. 
9. TEST FOR TERPENOIDS 
A little of the powdered leaf was extracted with chloroform and filtered. The 
filtrate was warmed gently with tin and thionylchloride. Pink color solution appeared 
which indicated the presence of terpenoids. 
10. TEST FOR THE PRESENCE OF VOLATILE OIL 
Weighted quantity (250 gm) of fresh leaves were extracted and subjected to 
hydro distillation using volatile oil estimation apparatus. No volatile oil was obtained 
indicating the Absence of volatile oil. 
11. TEST FOR MUCILAGE 
Few ml of aqueous extract prepared from the powdered crude drug was treated 
with ruthenium red. No Red colour was produced indicating the absence of mucilage. 
SECTION – B 
QUANTITATIVE ESTIMATION OF PHYTO-CONSTITUENTS 
Preparation of ethanolic extract of Ipomoea pes-caprae 
The shade dried and coarsely powdered leaves of Ipomoea pes-caprae was 
defatted with petroleum ether (60-80˚c) for three days by triple maceration. The 
defatted marc was extracted with 70% ethanol by triple maceration and filtered. The 
filtrate was concentrated under reduced pressure to obtain a solid residue which was 
dark green in colour. 
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 TOTAL PHENOLIC DETERMINATION
[82-84] 
Principle 
 Total phenolic content of the various concentrations of extract of Ipomoea 
pes-capraebyFolin-ciocalteu reagent method. 
All the phenolic compounds are oxidized by the Folin-Ciocalteu Reagent. This 
reagent, which is reduced during oxidation of the phenolic substances, into a mixture 
of blue molybdenum and tungsten oxides. 
The blue colour produced has a maximum absorption at about 750-760 nm. 
The absorption is proportional to the quantity of oxidized phenolic compounds. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents required 
a) FolinCiocalteu Reagent (1N) 
The Folin-ciocalteu reagent is a mixture of phosphomolybdate and 
phosphotungstate. Commercially available Folin-ciocalteu reagent (2N) was diluted 
with an equal volume of distilled water. The resultant solution was kept in a brown 
color bottle and stored in refrigerator at 4 ºc. 
b)Sodium carbonate solution (10%) 
 Sodium carbonates 350 gm was dissolved & makes the volume up to 1000 
mL& heat the solution at 70-80°c, then cool & filter with glass wool & keep it 
overnight. 
c)Standard gallic acid solution. 
Procedure 
About 1 mL (1mg/ml and 0.5 mg/mL) of ethanolic extracts of Ipomoea pes-
caprae 0.5 mL of Folin-ciocalteu reagent (1N) were added and allowed to stand for 
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15 minutes. Then 1 mL of 10% sodium carbonate solution was added to the above 
solution. Finally the mixtures were made up to 10 mL with distilled water and 
allowed to stand for 30 minutes at room temperature and total phenolic content was 
determined spectrophotometrically at 760nm wavelength. 
             The calibration curve was generated by preparing Gallic acid at different 
concentration (2, 4, 6, 8 and 10 µg/mL). The reaction mixture without sample was 
used as blank. Total phenolic content of IPC extract is expressed in terms of mg of 
Gallic acid equivalent per gm of extract (mg GAE/g). The results are tabulated in 
table 7 and the calibration graph was presented at Fig 16. 
TOTAL FLAVONOID DETERMINATION
[85-87]
 
Principle
 
.
The aluminum chloride colorimetric technique was used for estimation of 
total flavonoid estimation. Aluminum ions form stable complexes with C4 keto group 
and either to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It 
also forms acid labile complexes with ortho hydroxyl groups in the A or B rings of 
flavanoids. These complexes showed a strong absorption at 415 nm which is used for 
the estimation of flavonoids.
 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents required 
10% aluminum chloride 
1M potassium acetate 
Procedure 
1mL of ethanolic extracts of Ipomoea pes-caprae, 0.1 mL of aluminum 
chloride solution, 0.1 mL of potassium acetate solution and 2.8 mL of ethanol were 
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added and the final volume was then made up to 5 mL with distilled water. After 20 
min the absorbance was measured at 415 nm.  
A calibration curve was constructed by plotting absorbance reading of 
quercetin at different concentrations. The sample without aluminium chloride was 
used as a blank. The total flavonoid content in the extract was expressed as milligrams 
of quercetin equivalent per gram of extract and the results were tabulated in table 8. 
(Fig.17) 
 TOTAL TANNIN DETERMINATION
[88,89]
 
Principle  
 Total tannin content of extract was determined by Folin Denis reagent method.                
           Tannin like compounds reduces phosphotungstomolybdic acid in alkaline 
solution to produce a highly coloured blue solution. The intensity of which is 
proportional to the amount of tannins and it was estimated by spectrophotometer at 
700 nm. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents required 
a) Folin Denis Reagent ( sodium tungstate 100 g and phospho molybdic acid  20 
gm were dissolved in distilled water 750 mL along with phosphoric acid 50 
mL. The mixture was refluxed for 2 hours and volume was made up to 1 litre 
with distilled water )  
b) Sodium carbonate solution (10%) 
c) Standard tannic acid solution. 
 
 
Materials and methods 
 
Department of Pharmacognosy, MMC, Madurai. 37 
 
Procedure 
0.2 mL of (1 mg/mL) ethanolic extract of Ipomoea pes-caprae, was made 
upto1 mL with distilled water. Then add 0.5 mL of Folin Denis reagent and allowed 
to stand for 15 mins, then 1 mL of sodium carbonate solution was added to the 
mixture and it was made up to 10 mL with distilled water. The mixture was allowed 
to stand for 30 mins at room temperature and the tannin content was determined 
spectrophotometrically at 700 nm. 
The calibration curve was generated by preparing tannic acid at different 
concentration (4, 8, 12, 16 and20 µg/mL). The reaction mixture without sample was 
used as blank. The total tannin content in the leaf extract was expressed as milligrams 
of tannic acid equivalent per gm of extract. The results were tabulated in table 9.              
(Fig 18)  
SECTION –C 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
Analysis and quantification of kaempferol in Ipomoea pes-caprae extract by 
HPLC
 
 HPLC studies of IPC extract was carried out in order to identify  and quantity 
the active principles present in the extract. 
Materials and methods
[91,92] 
Instrument  -  Agilent technologies 1220 infinity LC (USA) 
Column  - Agilent Zorbax SB – C 18 
Flow rate  - 1.2 mL / min 
Injection volume  -           10 µL  
Standard  - Kaemperol ( 5mg/ 100mL of methanol ) 
Sample  - Ipomoea pes-caprae (0.1g/100 mL of methanol) 
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UV Detector      - 270 nm 
Temperature  - 30 ˚c  
Software  - Open LAB,CDS chem station work station VL 
Mobile phase              -    The mobile phase was prepared using 1 %(v/v) 
tetrehydrofuran  in deionized distilled water adjusting to pH 3.0 with H3 PO4. The 
flavonoids   were separated using the following gradient; 30 %(v/v) CH3 CN 
(acetonitrile) for 8 mins,100 % CH3 CN for 3 mins,100 % CH3 CN for 4 mins. 
 Linearity graph was generated by plotting the different concentration of the 
standard in the X axis (3.81, 7. 61, 11.42, 15.23, 19.04 µg/ mL) and the area of the 
peak in Y axis. 
The linear regression equation was calculated as y = 35.3123x- 5.7080,              
R
2
 = 1.0000.The result of the standard and sample chromatogram are presented in 
Fig19-25. 
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PART III- PHARMACOLOGICAL SCREENING 
SECTION- A 
IN VITRO ANTIOXIDANT ACTIVITY 
Method 1 ; Determination of scavenging activity against hydrogen peroxide
[93-95]
 
Principle  
   The radical scavenging activity against hydrogen peroxide of plant extract 
was determined by using the method of Jananiet al (2011). The principle is based on 
the capacity of the extract to decompose the hydrogen peroxide to water. H2O2 in the 
presence of O2 - can generate highly reactive hydroxyl radicals via the metal, the 
scavenging of H2O2 in cells is critical to avoid oxidative damage. Thus, the 
scavenging of hydrogen peroxide is an important antioxidant defence mechanism. 
Fe2+ + H2O2                 Fe3+ + OH + OH-  
The decomposition of hydrogen peroxide to water involves the transfer of electrons as 
in equation 
H2O2 + 2H+ + 2e-                     2H2O 
Reagents 
6% hydrogen peroxide diluted with water in the ratio of 1:10 
0.1M, pH 7.4 phosphate buffer  
Procedure 
 To 1 mL of test solutions of different concentrations, 3.8 mL of 0.1 M 
phosphate buffer solution (pH 7.4) and then 0.2 mL of hydrogen peroxide solution 
were added. The absorbance of the reaction mixture was measured at 230 nm after 10 
min. The reaction mixture without sample was used as blank. Sample blank was also 
prepared without reagents. Ascorbic acid was used as standard. The percentage 
inhibition of hydrogen peroxide was calculated using the formula      
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% inhibition    =   (A control – A sample) / A control X 100 
The concentration of the sample required for 50 % reduction in absorbance 
(IC50) was calculated using linear regression analysis. The results obtained are 
presented in table 10.             (Fig. 26). 
Method 2; Diphenylpicrylhydrazyl (DPPH) method
[96-98] 
Principle 
DPPH is a stable free radical with a distinctive ESR signal. Its reaction with 
antioxidants can be followed by the loss of absorbance at 517 nm.  It is widely 
accepted that DPPH accept an electron or hydrogen radical and become a stable 
diamagnetic molecule. Due to its odd electron, the ethanol solution of DPPH (purple 
colour solution) shows a strong absorption at 517 nm. DPPH radicals react with 
suitable reducing agents where the pairing of electrons takes place and the solution 
loses colour stochiometrically with the number of electrons taken up. 
DPPH
.
  + AH → DPPH-H  +  A. 
Instrument  
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.1mM diphenylpicryl hydrazyl in ethanol 
Procedure 
A stock solution of DPPH was prepared in ethanol (4 mg/100 ml). To the 1 
mL of test samples of different concentrations 4 mL of DPPH was added. Control 
without test compound was prepared in an identical manner. Blank was prepared in 
the similar way, where DPPH was replaced by ethanol. The reaction was allowed to 
be completed in the dark for about 30 min. Then the absorbance of test mixtures was 
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read at 517 nm. The percentage inhibition was calculated and expressed as percent 
scavenging of DPPH radical. Vitamin C was used as standard. 
The percentage scavenging was calculated using the formula 
% inhibition    =   (A control – A sample) / Acontrol X 100 
The concentration of the sample required for 50 % reduction in absorbance 
(IC50) was calculated using linear regression analysis. The results obtained are 
presented in table 11.             (Fig 27) 
Method 3; Total antioxidant activity by phosphomolybdenum method
[99,100]
 
Principle 
The total antioxidant activity of the extract was evaluated by 
phosphomolybdenum method. The assay is based on the reduction of Mo (VI) to Mo 
(V) by the sample and by the subsequent formation of green phosphate Mo (V) 
complex at acidic pH which has a maximum absorption at 695 nm. This method is 
routinely used to determine total antioxidant activity of samples. 
Mo
6+         →        Mo5+ 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.6M sulphuric acid   
28mM sodium phosphate 
4mM ammonium molybdate 
Procedure 
An aliquot of 0.3 mL of different concentrations of sample solutions was 
combined with 2.7 mL of the reagent solution (H2SO4, sodium phosphate and 
ammonium molybdate). In case of blank, 0.3 mL of methanol was used in place of 
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sample. The tubes were incubated in a boiling water bath at 95°C for 90 min. After 
the samples had cooled to room temperature, the absorbance of the aqueous solution 
of each was measured at 695 nm against blank. The standard vitamin C was treated in 
a similar manner. The antioxidant activity was expressed as equivalents of Vitamin C 
(µg/g). The results are tabulated in table 12.( Fig 28) 
Method4 : Reducing power assay 
[101,102]
 
Principle 
Reducing power assay is a spectrophotometric method and is based on the 
principle that increases in absorbance of the reaction mixture indicates the increases in 
the reducing power of the sample. Antioxidant activity may be due to a variety of 
mechanism viz., the prevention of chain initiation, the binding of transition metal ion 
catalysts, decomposition of peroxides, the reductive capacity and free radical 
scavenging.  The assay is based on the reduction of ferric in potassium ferricyanide to 
ferrous to form potassium ferrocyanide by the sample and the subsequent formation of 
Prussian blue colour with ferric chloride. The absorbance of the blue complex is 
measured at 700 nm.  
Potassium ferricyanide+  Ferric chloride   
                                     Antioxidant 
Potassium ferrocyanide + Ferrous chloride 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Materials required 
Ascorbic acid 
1 % w/v Potassium ferricyanide 
10 % w/v Trichloro acetic acid   
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0.2 M, Phosphate buffer (pH 6.6) 
0.1% w/v Ferric chloride 
Procedure 
The reducing power ability of plant extracts was screened by assessing the 
ability of the test extract to reduce FeCl3solution as mentioned by Oyaizu et al., 
(1986). 0.1 to 0.5 mL of plant extract solution (1 mg/mL) was mixed with 0.75 Ml of 
phosphate buffer and 0.75 mL of 1 % potassium ferricyanide [K3Fe(CN6)] and 
incubated at 50
o
C for 20min.0.75 mL of 1 % trichloro acetic acid was added to the 
mixture  and allowed to stand for 10min. The whole mixture was then centrifuged at 
3000 rpm for 10min. Finally 1.5 mL of the supernatant was removed and mixed with 
1.5 mL of distilled water and 0.1mL of 0.1 %ferric chloride solution and the 
absorbance was measured at 700 nm in UV-Visible Spectrophotometer.  Ascorbic 
acid was used as standard and phosphate buffer was used as blank solution. The 
results obtained are presented in table 13.(fig 29) 
SECTION - B 
EFFECT OF ETHANOLIC EXTRACTS OF Ipomoea pes-caprae ON 
VINCRISTINE INDUCED NEUROPATHIC PAIN IN RATS
 [103-110] 
 Neuropathic pain associated with peripheral nerve injury is characterized by 
the sensory abnormalities such as unpleasant and abnormal sensation (dysesthesia) an 
increased response to painful stimuli (hyperalgeia) and pain in response to stimuli that 
does not normally provoke pain(allodynia).
[5] 
MATERIALS AND METHODS 
Plant meterial 
 The fresh leaves were collected at Ramnad, Tamil Nadu and India. The plant 
material was authenticated by taxonomist. After authentication, fresh leaves of 
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ipomoea pes-caprae was cleaned thoroughly with distilled water and dried under 
shade. The shade-dried leaves were pulverized in a mechanical grinder. The powdered 
plant material passed through a sieve.(sieve no. 10/40). 
Chemicals and drugs 
 Vincristine sulfate was obtained from Chandra Bhagatpharma Pvt. Ltd., 
Mumbai, India. Pregabalin was procured from Glenmark and all the chemicals used 
were of analytical grade. 
Animals 
Wistar albino rats, weighing 200-300 g, were employed in the present study. 
The rats were exposed to 12 h light-dark cycles. The experimental protocol was duly 
approved by the Institutional Animal Ethics Committee. 
Induction of peripheral neuropathy 
 Peripheral neuropathy was induced in rats by administration of vincristine 
sulfate (50 µg/kg; i.p. daily) for 10 consecutive days. Behavioral test were assessed on 
different days. i.e. 0,1,3,6,9,12,15,18 and 21
st
. 
EXPERIMENTAL PROTOCOL 
 Eight groups, each comprising six Wistarrats were employed in the present 
study. 
Group I (Normal control group) 
 Rats were not subjected to administration of vehicle and vincristine and were 
kept for 24 days. Behavioral tests such as hot plate test, acetone drop test and tail 
immersion test were employed to assess nociceptive threshold of the hind paw on 
different day’s i.e. 0,1,3,6,9,12,15,18&21st .All the animals were sacrificed according 
to CPCSEA guidelines at the end of the 21
st
 day. Sciatic nerve of the animals were 
isolated and homogenated to estimate biochemical markers such as TBARS, reduced 
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glutathione, total protein and total calcium levels. Histopathological studies also 
carried with the distal portion of the sciatic nerve. 
Group II (vincristine 50 µg/kg,i.p) 
 Vincristine (50 µg/kg, i.p) was administered to the rats for 10 consecutive 
days. Behavioral tests were assessed as described in group I. 
Group III (IPC extract 200 mg/kg treated group) 
IPC extract (200 mg p.o) was administered two hours before each vincristine 
injection (vincristine was administrated daily for 10 days; 50 µg/mg, i.p) for 10 
consecutive days. Behavioral tests were assessed as mentioned in group I. 
Group IV (IPC extract 300 mg/kg treated group) 
 IPC (300 mg/kg  p.o) was administered two hours before each vincristine 
injection 
(vincristine was administrated daily for 10 days; 50 µg/mg, i.p) for 10 consecutive 
days. Behavioral tests were assessed as mentioned in group I. 
Group V ( Pregabaline 10mg/kg, treated group) 
 Pregabalin (10 mg/kg p.o) was administered orally two hours before each 
vincristine injection (vincristine was administered once in three days) for 14 
consecutive days. Behavioral tests were assessed as mentioned group I. 
SENSORY BEHAVIORAL ASSESMENT 
Hot plate test
[103] 
 Heat thermal sensitivity of the hind paw was assessed by using standard 
procedure for assessing the degree of noxious thermal sensation. The rats were placed 
on the top of a preheated (52± 0.5˚ c) hot plate. The hind paw withdrawal response 
was noted in seconds. The cut-off time of 20 seconds was maintained. (fig 30). 
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Tail immersion test
[104]
 
 Tail immersion test was carried out to assess the spinal heat thermal 
sensitivity. Tip of the rat’s tail was immersed in heat noxious temperature (52± 
0.05˚c) till the tail was withdrawn. Thermal heat hyperalesia was assessed by the tail 
withdrawl response, noted in seconds. The cut off time of 10 seconds was 
maintained.(fig 31) 
Acetone drop test (Paw cold-allodynia)
[105]
 
 Cold-allodynia of the hind paw was assessed using acetone drop method using 
standard procedure with slight modification, for evaluating the reactivity to non-
noxious cold chemical stimuli. The rats were placed on the top of a wire mesh grid, 
allowing access to the hind paws. Acetone (0.1 ml) was sprayed on the plantar surface 
of hind paw of rat and time taken for withdrawing the hind paw from the mesh surface 
was noted. The cut off time of 60 seconds (fig 32) 
 BIOCHEMICAL ESTIMATION OF MARKERS OF OXIDATIVE STRESS 
 All the groups of animals were sacrificed after 21
st
day by cervical dislocation 
and the sciatic nerve was isolated immediately and used for the biochemical 
estimation. The distal portion of the nerve, which was used for histopathological 
study. Freshly excised sciatic nerve homogenate (10 %) was prepared with 0.1 M 
TrisHcl buffer (P
H
-7.4) and the homogenate was kept in ice water for 30 min and 
centrifuged at 4˚c (2000 g,10 min).The supernatant of homogenate was separated and 
which was used to estimate following biochemical markers. 
Estimation of total protein content
[106]
 
The protein concentration was estimated according to the standard 
procedure
112
 using bovine serum albumin as a standard. The absorbance was 
determined spectrophotometrically at 750 nm. 
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Estimation of total calcium
[107,108]
 
 Total calcium level was estimated in sciatic nerve according to the standard 
procedure. Total calcium level was estimated in sciatic nerve. The sciatic nerve 
homogenate was mixed with 1 mL of trichloroaceticacid (4 %) as in ice cold 
condition and centrifuged at 1500 g for 10 mins. The clear supernatant was used for 
the estimation by atomic emission spectroscopy at 556 nm. 
Estimation of reduced glutathione
[109]
 
 Equal quantity of sciatic nerve tissue homogenate was mixed with 10 % 
tricholoroacetic acid and the mixture was centrifuged to separate proteins. To 0.01 mL 
of this supernatant, 2 mL of phosphate buffer(PH-8.4). 0.5 mL of 5’5 dithiobis (2- 
nitrobenzoic acid) and 0.4mL of distilled water were added. Mixture was vortexed 
and the absorbance was taken at 415 nm with 15 mins. The concentration of reduced 
glutathione was expressed as µg/mg of proteins. 
Estimation of TBARS 
 The thiobarbituric acid reactive substance (TBARS) level was estimated as per 
the standard procedure. To each test tube,0.5 mL of supernatant,0.5 mL normal saline, 
1 mL of 20 % tricholoroacetic acid (TCA) AND 0.25 mL of TBA reagent (200 mg of 
thiobarbituric acid in 30 mL distilled water and 30 mL of acetic acid) were added. The 
test tubes were kept for boiling at 95˚ c for one hour. To each test tube, 3 mL of n-
butanol was added and mixed well. These test tubes were centrifuged at 3000 rpm for 
10 minutes. The separated butanol layer was collected and read in a 
spectrophotometer against blank at 535 nm. Concentration of thiobarbituric reactive 
substance was expressed in terms of nmolmalondialdehyde per mg of protein. The 
results are presented to table 14. 
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Histopathology studies
[110] 
 Samples of sciatic nerve were stored in fixative solution (10 % formalin) and 
cut in to 4 µm thickness. Staining was done by using hematoxylin and eosin as 
described by standard procedure. Nerve sections were analysed qualitatively with a 
light microscope (450x) for axonal degeneration.(Fig 33) 
Statistical analysis 
 All the results were expressed as mean ± standard error of means (SEM). The 
data from the behavioral results were statistically analysed by two-way analysis of 
variance followed by bonferroni’s post hoc-test by using graph pad prism v.5.0 
software. The data from the biochemical results were statistically analysed by one-
way ANOVA followed by Tukey’s multiple range tests. p˂ 0.05 was considered to be 
statistically significant. 
SECTION - C 
IN VITRO MEMBRANE STABILISATION STUDY 
[111-113]
 
Principle 
             The method in vitro membrane stabilization activity assay was carried out 
according to the established and standard procedure. When RBCs are subjected to 
heat and treatment with hyposaline, they release haemoglobin which has a maximum 
absorbance at about 560 nm. The capacity of the extract to reduce hyposaline and heat 
induced lysis is basis of the assay.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.2M sodium phosphate buffer (pH 7.4) 
0.36% w/v hyposaline 
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10%v/v HRBC suspension in isosaline 
Preparation of HRBC suspension in isosaline 
The human erythrocytes suspension was used for the in vitro membrane 
stabilization assay. Blood was collected from healthy volunteers who had not 
consumed any NSAIDs for two weeks prior to the experiment. The blood was mixed 
with equal volume of Alsever solution (2% dextrose, 8.0 % sodium citrate, 0.5 % 
citric acid and 0.42 % sodium chloride) and centrifuged at 3000 rpm. The packed cells 
were washed with isosaline and a 10 % v/v erythrocyte suspension in isosaline was 
prepared.  
Procedure 
 The assay mixture consist of 2 mL of hyposaline and 1mL of phosphate buffer 
and varying volumes of the extract (0.1 to 0.5 mL) and 0.5 mL of HRBC suspension 
in isosaline, then the final volume were made up with isosaline up to 4.5 mL. The 
control was prepared as mentioned above except the drug was omitted, while drug 
control was also prepared similarly but without HRBC suspension. The reaction 
mixture was incubated at 56ºC for 30min in a water bath, then the tube was cooled 
under running water. Then the absorbance of the released hemoglobin was measured 
at 560 nm. Diclofenac 50 µg/mL was used as a reference standard. The percentage of 
membrane stabilization activity of the compounds were determined by the formula  
 % membrane stabilization =    [Acontrol- (A test - A product control) ] / Acontrol x 100 
 Acontrol  - Absorbance in control 
Atest  - Absorbance in test 
Aproduct control - Absorbance in product control 
The results obtained for in vitro membrane stabilization effect is presented in table 
15.(fig 34) 
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CHAPERT – 6 
RESULTS AND DISCUSSION 
PART – I PHARMACOGNOSTIC EVALUATION 
Section A – Macroscopic studies of leaves 
Colour   -  Dark green colour 
 Odour   -  Characteristic odour 
 Texture  - Coarse 
 Venation  - Pinnate  
 Leaf arrangement - Alternate 
 Leaf type  - Simple 
 Margin  - Lobed 
 Shape   - Eliptic (oval)  
Section – B Microscopic studies of the leaves 
Leaves 
The leaves has broad and thick midrib and thin lamina. The midrib consist of 
wide adaxial part, bowel shaped and thick abaxial part. It is 1.1 mm, adaxial cone is 
150 x 250 µm in size and the abaxial part is 1.8 mm wide.(Fig 11.1) 
 The epidermal layer around the midrib is intact and includes small, thick 
walled- squanish cells. The ground tissue is parenchymatous; the cells are angular or 
circular and compact. The cells in the adaxial cone are collenchymatous. The palisade 
zone extends up to the lateral shoulders of the adaxial cone. 
 The vascular strand is shallowly saucer shaped. It is 300 µm thick and 1 mm 
broad.The vascular strand consists of three or four separate units of bi-collateral 
bundles. In each bundle occur short, radial lines of three or four xylem elements. The 
elements are wide, angular and thick walled. The Metaxylem elements are 40 µm 
wide. 
FIG 4: HERBERIUM OF Ipomoea pes-caprae  
 
  
FIG 5: HABIT AND HABITAT OF Ipomoea es-capare 
 
 
 
 
 
 
 
 
 
 
 
FIG 6:BUDS OF Ipomoea pes-        FIG 7:FLOWER OF Ipomoea pes 
capare                     capare 
 
 
 
FIG 8: LEAVES OF Ipomoea pes-caprae 
 
DORAL LEAF             VENTRAL LEAF      
                                                  
 
 
 
FIG 9: SEEDS OF Ipomoea pes-caprae          FIG 10: STEM OF Ipomoea pes  
     caprae 
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 The phloem elements are small, thick walled and darkly stained. They are 
present in both adaxial and abaxial sides of the vascular bundle. The abaxial phloem 
units are thick and circular masses. The abaxial units are small clusters.(fig 12.1,12.2) 
Lamina 
 The lamina is bifacial (heterofacial), amphistomatic and mesomorphic. The 
lamina is 340 µm thick. The adaxial epidermis is thin and the cells are narrow and 
cylindrical. The abaxial epidermis is thick and it consists of rectangular- oblong cells. 
The stomata are slightly raised above the epidermal surface. The mesophyll tissues 
are differentiated into adaxial band of vertical filaments; the filament is two or three 
cells and loosely arranged. The spongy parenchyma cells are short and cylindrical and 
forms a reticulate system of aerenchyma (fig11.2). 
Epidermal cells and stomata 
 The stomata and epidermal cells are observed in the paradermal (parallel to the 
epidermal surface) sections. The epidermal cells are polygonal with straight, thick anti 
clinal walls. Stomata of both adaxial and abaxial sides are paracytic type (fig 13.1). 
The stoma has two subsidiary cells, one or either side and parallel guard cells (fig 
13.2). The guard cells are 20 x 40 µm in size. 
Glandular trichomes 
 Peltate type of glandular trichomes are common on the epidermal layer. The 
gland has a short one-celled stalk and circular 8- celled flat head. The gland is 30 µm 
in diameter.(fig 13.3) 
Venation  
 The venation is densely reticulate. The secondary and tertiary veins are 
uniformly thin. The vein islets are wide and poly hedral in outline. Veinlet terminatios 
are either simple and unbranched; more commonly they are branched forming 
FIG. 11.1
T.S. of Leaf of Ipomoea pes-caprae  through midrib
FIG. 11.2
T.S. of Lamina
Adaxial cone
Lamina
Vascular Strand
Ground Tissue
Abaxial Side
Adaxial Stomata
Palisade Mesophyll
Adaxial Epidermis
Spongy Mesophyll
Abaxial epidermis
Abaxial Stoma
FIG. 12.1
Abaxial  Phloem
FIG. 12.2
Adaxial Phloem
Collenchyma
Palisade Mesophyll
Adaxial Phloem
Vascular bundle
Xylem
Ground tissue
Abaxial Phloem
Epidermis
Adaxial Phloem
Abaxial Phloem
Xylem
FIG. 13.1
Paradermal section of the abaxial epidermal 
layer showing the stomata
FIG. 13.2
Single paracytic stomata
FIG. 13.3
Glandular trichome in surface view
Epidermal cells
Anticlinal walls
Stoma
Subsidiary cells
Subsidiary cells
Stoma
Glandular trichome
FIG. 14.1
Reticulate venation system of the lamina
FIG. 14.2
Dendroid vein-termination with terminal tracheids
Vein termination
Vein islet
Vein termination
Vein islet
Terminal tracheid
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dendroid outline. At the ends of the vein termination, they are small clusters of 
terminal tracheids. (fig 14.1, 14.2). 
Section – C Quantitative microscopy[69] 
 The results obtained for the determination of leaf constants like stomatal 
number, vein termination index and palisade ratio are presented in table 1 
Table 1: Quantitative microscopical parameters of the leaf of Ipomoea pes-caprae 
 
 
 
 
 
 
 
*mean of three readings ± SEM 
Section D- Powder microscopy and analysis 
 Trichomes  - glandular epidermal trichomes 
 Stomata  -  Paracytic 
 Collenchymas cells 
 Parenchyma cells 
 Xylem 
 
 
S. No. Parameters 
Values* 
obtained 
1 Stomatal number        52.43 
2 Stomatal index       14.65 
3 Vein islet number       8.92 
4 Vein termination number        11.28 
5 Palisade ratio          4.32 
FIG. 15
Powder microscopy of Ipomoea pes-caprae
Paracytic stomata Glandular trichome,
epidermis surface view
Collenchyma
Parenchyma
Xylem vessels
Phloem
Sieve tubeCompanion cell
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Fluorescence analysis
[79] 
The organic molecules absorb light usually over a specific range of wave 
length and many of them emit such radiations. So if the powder is treated with 
different chemical reagents and seen in the UV chamber, different colours will be 
produced. The results of fluorescence analysis revealed the purity of this plant 
material 
[78]
. The result is presented in table-2. 
Table: 2 Fluorescence Analysis of extracts of Ipomoea pes-caprae 
Extracts Consistency Colour in Day 
Light 
Colour under UV Lamp 
 366 nm 254nm 
Petroleum 
extract 
Semisolid Yellow Orange Yellow 
Ether 
Extract 
Semisolid Greenish brown Green 
Greenish 
brown 
Chloroform 
extract 
Semisolid Brownish green Orange Orange 
Ethanol 
Extract 
Semisolid Light green Green Orange 
Methanol 
extract 
Semisolid Green Dark green Orange 
Aqueous 
extract 
Semisolid Brown 
Brownish 
green 
Dark green 
Section E – Physical parameters 
 The result of the ash value,acid insoluble ash value and water soluble ash 
value presented in table 3 .Total ash of the drug is inclusive as well as physiological 
ash.  Physiological ash and non-physiological ash. Physiological ash is derived from 
the plant tissues. While non-physiological ash consists of residue of the extraneous 
matter(such as sand, soli etc),adhering to the herb itself. Many a time the crude drug 
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are admixed with various mineral substance like sand, soli, calciumoxalate, chalk 
powder or other drugs with different inorganic contents. For determining ash, the 
powdered drug is incinerate as to burn out all organic matter. Ash value is criterion to 
jude the identity or purity of crude drugs. Total ash usually consists of carbontes, 
oxides, phosphates, silicates and silica. Adhering dirt and sand may be determined by 
acid insoluble ash. 
Table: 3 Analytical parameters of Ipomoea pes-caprae 
S. No Parameters Values* expressed as % 
1. Foreign organic matter 0.01 ± 0.12 
2. Moisture content 11.85 ± 0.46 
3. Ash values  
 Total ash 8.01 ± 0.35 
 Acid insoluble ash 4.32 ± 0.47 
 Water soluble ash 4.2±0.90 
 Water insoluble ash 7.8 ± 0.91 
         *mean of three readings ± SEM 
Extractive values 
The result of the extractive values are presented in table 4. The extracts 
obtained by exhausting crude drug are indicative of approximate measure of their 
chemical constituents. Taking in to consideration the diversity in chemical nature and 
properties of contents of drugs, various solvents are used for determinations of 
extractives. The solvent used for extraction is in a position to dissolve appreciable 
quantities of substance desired. Highest extractive value was obtained for the hydro-
ethanolic extractive of this plant (15.76%). It indicates that therapeutically viable 
active principles are predominantly present in hydro-ethanolic extract. Hence this 
extract was chosen for phyto chemical and pharmacological studies. 
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Table: 4 Analytical parameters – Extractive values of Ipomoea pes-caprae 
S. No Parameters* Values* expressed as% 
1. Extractive Values  
 Petroleum extract 1.59± 0.48 
 Chloroform extract 5.59± 0.04 
 Ethanol extract                       3.19 ±0.81 
 Hydro ethanolic extract(Ethanol: 
Water, 70; 30) 
15.76 ±0.71 
 
 Methanol extract 13.57 ± 0.01 
 Aqueous extract 9.67± 0.74 
2. Foaming index less than 100 
3. Swelling index expressed as  ml 
 Initial volume  3.6 ± 0.20 
 Final volume  10.3 ± 0.97 
*mean of three readings ± SEM 
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PART II – PHYTOCHEMICAL EVALUATION 
Section–A Preliminary phytochemical studies 
Preliminary phytochemical study was performed for various extracts and 
powdered leaf material of Ipomoea pes-caprae and the results are tabulated in table 5 
and 6. 
Table: 5 
Preliminary phytochemical screening for the leaf powder of Ipomoea pes-caprae 
S.NO TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test + 
 b. Biuret test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendroff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
 e. Test for Purine group (Murexide test ) - 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides + 
 i) Borntrager’s test + 
     ii) Modified Borntrager’s test + 
 b. Cardiac glycosides  
 i) Keller Killiani test - 
 c. Cyanogenetic glycosides - 
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6. TEST FOR SAPONINS + 
7. TEST FOR TANNINS  
 Fecl3 test + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TERPENOIDS + 
10. TEST FOR VOLATILE OILS - 
11. TEST FOR MUCILAGE - 
(+) indicates positive reaction                 (-) indicates negative reaction 
Table: 6 Preliminary phytochemical screening for the various extracts of leaf 
powder of Ipomoea pes-caprae 
S. 
No. 
Chemical Test 
Hexane 
extract 
Petrole
um 
ether 
extract 
Chlorof
orm 
Methann
olic 
extract 
Ethan
olic 
extract 
Aqueo
us 
extract 
1. Terpenoids + + + + + - 
2. Flavonoids - - - + + + 
3. Phyto sterols + + + + + - 
4. Anthraquinone 
glycosides 
- - - + + + 
5. Cardiac 
Glycosides 
- - - + + - 
6. Sugars - - - + + + 
7. Alkaloids - - - + + - 
8. Quinones - - - - - - 
9. Phenols - - - + + + 
10. Tannins - - - + + + 
11. Saponins - - - + + + 
12. Proteins & free 
amino acids 
- - - + + + 
(+) indicates positive reaction                 (-) indicates negative reaction 
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The rsults of the preliminary phytochemical studies showed the presence of 
terpenoids, tannins, phyto sterols, alkaloids, glycosides, flavonoids and saponins. 
Section B – Quantitative estimation of phytoconstituents   
Total Phenolic Content 
In the present study, total phenolic content present in the extract was estimated 
using modified Folin- ciocalteau method. Values are expressed as gallic acid 
equivalents and the results are tabulated in table 7. Total phenolic content for 
ethanolic extract of Ipomoea pes-caprae was found to be 22.27±0.19 mg/g.The linear 
regression equation was found to be y=0.116x-0.004 while the correlation was found 
to be 0.9998.(fig 16) 
  Table 7 Total phenolic content in ethanolic extract of Ipomoea pes-caprae 
S.NO 
Con.c 
of 
gallic 
acid in 
µg/ml 
Absorbance 
Con.c of 
ethanolic 
extract in 
µg/ml 
Absorance 
Amount of 
total phenolic 
content in 
terms mg 
GAE/g of 
extract* 
1 2 0.229 ± 0.010 50 0.138±0.001 23.97±0.25  
2 4 0.452 ± 0.006 100 0.243±0.001 20.98±0.13 
3 6 0.695 ± 0.005  
  
4 8 0.918 ± 0.031  
5 10 1.162 ± 0.028  Average  22.27±0.19 
* mean of three readings ±SEM 
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Fig.16 : Calibration graph of gallic acid 
 
Phenolics are the most widely distributed secondary metabolite in plant 
kingdom. These groups of compounds have much attention as potential natural 
antioxidants in terms of their ability to act as both efficient radical scavengers and 
metal chelator. It has been reported that the antioxidant activity of phenolic 
compounds are mainly due to their redox, hydrogen donating properties and singlet 
oxygen quenchers.
[90]
 
Estimation of Flavonoid: 
Flavonoid contents were determined by colorimetric method using AlCl3. The 
flavones and flavonols react and form more stable complexes with Aluminium 
chloride. The amount of flavonoid was considered as the important index for 
evaluating the biological activity of drugs.  
Total flavonoid content for ethanolic extract of leaves of Ipomoea pes-capare 
was found to be217.1±0.37 mg/g respectively. The linear regression equation was 
found to be y = 0.0307x - 0.0432 while the correlation was found to be 0.9974.              
(fig 17) 
 
Calibration curve of gallic acid
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Table 8 Total flavonoid content of ethanolic extracts of Ipomoea pescaprae 
S. No. 
Conc. of 
quercetin in 
µg/Ml 
Absorbance 
Conc. of 
ethanolicextr
act in µg/Ml 
Absorbance 
Amt of total 
flavonoid content in 
terms of mg 
quercetin equivalent/ 
g of extract 
1 20 0.589 ± 0.01 100 0.26±0.001 202.2±0.96 
2 40 1.151 ± 0.04 200 0.66±0.002 232.1±10.79 
3 60 1.710 ± 0.09  
  
4 80 2.390 ± 0.03  
5 100 3.112 ± 0.03  Average 217.1±0.37 
                    *mean of three readings ± SEM 
Fig. 17:  Calibration curve of Quercetin 
 
Flavonoids are the most diverse group of polyphenols and are consist of a 
basic C6-C3-C6 flavone skeleton. Six classes of flavonoids are widespread in higher 
plant, and include the chalcones, flavanones, flavandiols, flavones, anthocyanins, 
catechins, and condensed tannins. Its antioxidative activity is dependent on the 
chemical structure, such as the number of hydroxyl groups substituted on the B ring. 
Intake of flavonoids has been associated to decrease the incidences of cancer, heart 
disease.[
89] 
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Total Tannin Content 
 Total tannin determination is carried out by spectrophotometry after oxidation 
of the analyte with the Folin–Denis reagent in alkaline medium. This method is based 
on a redox reaction and other reducing agents in the samples. 
 Total tannin content for ethanolic extract of leaves of Ipomoea pes-caprae was 
found to be 157.25±3.99 mg/g respectively. 
Table 9 Total tannin content in ethanolic extracts of Ipomoea pes-
caprae 
S. 
No. 
Conc. of 
Tannic 
acid in 
µg/Ml 
Absorbance  
Conc. of 
ethanolic 
extract 
in µg/ml 
*Absorbance 
*Amt of total Tannin 
content in terms mg 
tannic acid equivalent/ g 
of extract 
1 20 0.589 ± 0.01 10 0.03±0.000 124.3±0.46 
2 40 1.151 ± 0.04 20 0.05±0.0005 114.2±0.28 
    3       60 1.710 ± 0.09 40 0.07±0.0005 75.81±0.07 
4 80 2.390 ± 0.03    
5 100 3.112 ± 0.03 
    Average 157.25±0.99 
 *mean of three readings ± SEM 
 The linear regression equation was found to be y = 0.022x + 0.003 while the 
correlation was found to be table 9.  The amount of tannin content present in the 
ethanolic extract of Ipomoea pes-caprae was found to be 157.25±0.99mg/g 
respectively.(fig 18) 
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Fig 18: Calibration curve for Tannic acid 
 
 It is known that plant tannin can be precipitated by many chemical reagents 
and these precipitation techniques have become the tool for the estimation. Tannins 
are antioxidants phytoconstituents. 
Section C – High performance liquid chromatography 
Analysis and quantification of kaempferol in Ipomoea pes-caprae   extract by 
HPLC 
 The results of the HPLC chromatogram of standard kaempferol and IPC 
extract are presented in (fig 19-25) and table 10. HPLC chromatogram revealed that 
the retention time (tR) of standard kaempferol was found to be 5.88 mins (tR). The 
retention of a peak appeared in the chromatogram of IPC extract was found to be 5.87 
mins (tR) and it indicates the presence of kaempferol in the IPC extract. The 
percentage content of kaempferol  present in the air dried leaf plant material of IPC 
was calculated as 0.034 %. So for kaempferol has not been reported in this plant, but 
it has been reported in other species of this plant.
[92] 
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Fig-19 HPLC Chromatogram of kaempferol (Dil. Methanol) 
 
 
 
 
 
Name RT[min] Area Area % TP TF
 Sum  
 
  
  
 
 
Fig- 20 HPLC Chromatogram of  kaempferol (19.04 µg/mL ) 
 
  
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
KAEMPFEROL 5.88 665.26 100.00 4967 1.49
 Sum 665.26 100.00  
 
  
  
 
 
 
Fig- 21 HPLC Chromatogram of kaempferol (15.23 µg/mL ) 
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
KAEMPFEROL 5.88 533.50 100.00 5544 1.58
 Sum 533.50 100.00  
 
  
  
 
 
Fig-22 HPLC Chromatogram of kaempferol (11.42 µg/mL ) 
 
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
KAEMPFEROL 5.88 397.52 100.00 6028 1.63
 Sum 397.52 100.00  
 
  
  
 
 
Fig -23 HPLC Chromatogram of kaempeforl (7.61mg/mL ) 
 
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
KAEMPFEROL 5.88 263.70 100.00 6230 1.67
 Sum 263.70 100.00  
 
  
  
 
 
Fig -24 HPLC Chromatogram of kaempferol (3.81 mg/mL ) 
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
KAEMPFEROL 5.88 127.99 100.00 6422 1.65
 Sum 127.99 100.00  
 
  
  
 
 
Fig -25 HPLC Chromatogram of IPC extract 
 
 
 
 
 
 
Name RT[min] Area Area % TP TF
 2.13 30.07 2.21 290 0.66
 2.60 793.88 58.23 1079 0.85
 2.96 176.75 12.96 1250 2.94
KAEMPFEROL 5.87 362.76 26.61 3770 1.21
 Sum 1363.46 100.00  
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PART – III PHARMACOLOGICAL EVALUATION 
Section A - In vitro ant oxidant activity 
 Antioxidants obtained from plant are of greater benefit in comparison to 
synthetic one.  It protects against free radicals and they are therefore essential in 
obtaining and preserving good health. 
Method 1 :Hydrogen peroxide scavenging activity assay: 
The ethanolic extracts of Ipomoea pes-caprae was also evaluated for hydrogen 
peroxide scavenging activity assay. Hydrogen peroxide is a weak oxidizing agent and 
can inactivate a few enzymes directly, usually by oxidation of essential thiol (-SH) 
groups. Hydrogen peroxide can cross cell membranes rapidly, once inside the cell, 
H2O2 can probably react with Fe
2+,
 and possibly Cu
2+
 ions to form hydroxyl radical 
and this may be the origin of many of its toxic effects. It is therefore biologically 
advantageous for cells to control the amount of hydrogen peroxide that is allowed to 
accumulate. The decomposition of H2O2 by I. pes-caprae may at least partly result 
from its antioxidant and free radical scavenging activity. 
H2O2 + Cu+ or Fe
2+
 → Cu2+ or Fe3+ + OH + ·OH- 
The scavenging of hydrogen peroxide by ethanolic extracts of Ipomoea pes-
caprae may be due to the presence of phenolic compounds. IC50and percentage 
inhibition of hydrogen peroxide scavenging activity of ethanolic extract was tabulated 
in table 10.(fig 26) 
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  Table-10 Percentage inhibition of EEIPC by hydrogen peroxide method 
S. No. Conc. in 
μg/mL 
Percentage inhibition by 
standard ascorbic acid 
Percentage inhibition 
by EEIPC 
1 40 42.72±0.68 37.2±0.34 
2 80 71.08± 0.89 53.83±1.14 
3 120 82.7± 0.96 66.9±0.95 
4 160 85.45± 0.86 71.0±0.83 
5 200 92.42± 0.65 77.2±0.82 
 IC50 71.32µg/mL 97.28µg/Ml 
   * mean of three readings± SEM  
FIG 26; Determination of scavenging activity of IPC extract against hydrogen 
peroxide 
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The scavenging of the DPPH radical by hydrogen donating antioxidant is 
characterized by a rapid decline in the absorbance at 517 nm. The rapid reaction 
between antioxidants and DPPH occurs with the transfer of the most labile H atoms to 
the radical, while the subsequent slow step depends on the residual H-donating 
capacity of antioxidant degradation products. The antioxidants react with DPPH and 
convert it to 1, 1-diphenyl-2-picryl hydrazine with decolouration (from deep violet to 
light yellow). 
 
Ascorbic acid is used as standard. The radical scavenging activity of ethanolic 
extract Ipomoea pes-caprae is tabulated in table 11. 
Table 11: DPPH radical scavenging assay of IPC extract  
S. No. Conc. in 
μg/mL 
Percentage inhibition by 
ascorbic acid 
Percentage 
inhibition by Extract 
1 40 76.44±1.68 65.86±0.55 
2 80 81.22±1.22 72.77±0.69 
3 120 90.33±2.38 82.75±0.32 
     4 160 93.45±1.47 85.92±0.87 
5          200 95.68±2.02 89.24±0.63 
 IC50 40.67µg/mL 56.52µg/mL 
   *mean of three readings±SEM 
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FIG 27 :Determination of scavening activity of IPC extract against DPPH 
method 
 
Method 3: The total antioxidant capacity: 
Free radical scavenging of phenolic compounds is an important property 
underlying their various biological and pharmacological activities. The 
Phosphomolybdenum assay is based on the reduction of Mo (VI) to Mo (V) by 
antioxidant compounds and a formation of green phosphate/ Mo (V) complex with a 
maximal absorption at 695 nm. The anti oxidant assay of EEIP due to presence of 
phenolic compounds and flavonols. Total antioxidant capacity of EEIP was presented 
in table 12.(fig 28) 
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Table 12: Percentage inhibition of IPC extract by Phosphomolybdenum method  
S. No. 
Conc. in 
μg/mL 
Percentage 
inhibition by 
standard ascorbic 
acid 
Percentage inhibition 
by extract 
1 
100 0.373±0.06 0.26±0.03 
2 200 0.561±0.01 0.43±0.03 
3 
300 0.747±0.04 0.65±0.01 
4 
400 0.935±.007 0.81±0.001 
5 
500 1.10±0.09 0.99±0.05 
*mean of three readings ± SEM 
 
FIG 28 :Total antioxidant assay of IPC extract 
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Method 4 : Reducing power assay  
The results obtained for the free radical scavenging activity against Reducing 
power assay are presented in Table 15. (fig 29) 
 
   Table 13 : Reducing power assay of  IPC extract  
S. No. 
Conc. in 
μg/Ml 
Percentage 
inhibition by 
standard ascorbic 
acid 
Percentage 
inhibition by 
extract 
1        100      0.369±0.03 0.31±0.009 
2        200      0.565±0.01 0.46±0.02 
3 300      0.776±0.04 0.69±0.04 
4 400      1.06±0.01 0.95±0.02 
5         500 1.098±0.02 0.99±0.05 
  *mean of three readings ± SEM 
FIG 29; Reducing power assay of IPC extract 
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Section B- Effect of ethanolic extracts of IPC extract on vincristine induced 
neuropathic pain in rats 
Effect of IPC extract on paw heat hyperalgesic test  
 Administration of vincristine caused significant development noxious thermal 
hyperalgesia noted by decrease in hind paw withdrawal threshold after 3
rd
 day of 
vincristine administration when compared to normal control group. Vincristine 
induced, decrease in nociceptive threshold for thermal hyperalgesia was improved by 
the administration of IPC (200 and 300 mg/kg, p.o.) in a dose dependent manner ( 
p<0.05). Treatment of pregabalin also produced similar effects. Normal control group 
of animals did not show any significant effect on heat hyperalgesic test.(Fig 30) 
FIG. 30 Effect of IPC  extract on paw heat hyperalgesic test. 
 
Digits in parenthesis indicate dose in mg/kg. 
IPC 
Data were expressed as mean ± SEM, n=6 rats per group.
a
p<0.05 vs normal control 
group.
b
p<0.05 vs vincristine control group. 
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Effect of IPC on paw cold allodynia test 
 Vincristine teratment lead to the development of paw cold-allodynia  
indicateted by decrease in nociceptive threshold when compared to normal control 
group of animals.Treatment of IPC at 200 and 300 mg/kg,p.o. improved the 
nociceptive threshold in a dose dependent manner (p˂ 0.05).Similar result was 
obtained with pregabalin treatment. Normal control animals did not show any effect 
on paw cold allodynia test. (fig 31 ) 
FIG. 31 Effect of IPC extract on paw cold allodynia test. 
 
 
Digits in parenthesis indicate dose in mg/kg. 
IPC 
Data were expressed as mean ± SEM, n=6 rats per group.
a
p<0.05 vs normal control 
group.
b
p<0.05 vs vincristine control group. 
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Effect of IPC on tail immersion test 
 Vincristine administration caused significat development of noxious thermal 
hyperalgesia noted by decrease in a tail withdrawal threshold, after 3
rd
  day of 
vincristine administration when compared to normal control animals. Vincristine 
induced, decrease in nociceptive threshold for thermal hyperalgesia was improved by 
administration of IPC at 200 and 300 mg/kg,p.o. in adose dependent manner 
(p˂ 0.05). Treatment of pregabalin also produced similar effects.  Normal control 
animals did not show any effect on tail immersion test. (fig 32) 
FIG.32 Effect of IPC extract on tail heat hyperalgesia 
 
 
Digits in parenthesis indicate dose in mg/kg. 
IPC 
Data were expressed as mean ± SEM, n=6 rats per group. 
a
p<0.05 vs normal control. 
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 Effect of IPC on nerve tissue biomakers changes 
Vincristine administsrtion caused in asignificant increase in the levels of 
biomarkers i.e., total calcium and TBARS and decrease in the  level of GSH. 
Treatment of IPC extract at 200 and 300mg/kg, significantly attenuated the elevated 
total calcium and TBARS and increased the level of GSH in a dose dependent manner 
when compared to normal control group of rats (p˂ 0.05).Similar effect were seen 
with pregabalin administration.The results are persented in table 14. 
Table 14 Effect of IPC extract on tissue biomarker changes 
Groups 
Total Protein 
(mg /g of tissue) 
TBARS 
(nmol/mg of 
protein) 
GSH 
(µg/mg of 
protein) 
Total calcium 
(ppm/mg of 
protein) 
Normal 0.56 ± 0.22 2.97 ± 0.46 83.19 ± 1.97 3.04 ± 0.19 
Vincristine 0.62 ± 0.19 5.05 ± 0.27
a
 42.74 ± 3.64
 a
 23.18± 0.51 
a
 
Pregabalin (10) 0.67 ± 0.15 3.07 ± 0.37
 b
 79.63 ± 2.05
 b
 6.23± 0.34
b
 
IPC (200) 0.59 ± 0.27 3.98 ± 0.24
b
 61.73 ± 2.74
 b 
12.63 ± 0.28
b
 
IPC (300) 0.64 ± 0.14 3.43 ± 0.21
 b
 73.74 ± 2.84
b
 9.94 ± 0.52
 b
 
 
Digits in parenthesis indicate dose in mg/kg. 
TBARS, thiobarbituric reactive substances; GSH, reduced glutathione; 
IPC 
.Data were expressed as mean ± SEM, n= 6 rats per group. 
a
p<0.05 vs normal control 
group.
b
p<0.05 vs vincristine control group. 
group.
b
p<0.05 vs vincristine control 
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Histopathological studies 
The sciatic nerve of vincristine group showed  nerve derangement and axonal 
swelling. Treatment with hydroalcoholic extract of IPC (200 and 300mg/kg, p.o.) 
significantly attenuated vincristine induced histopathological alterations.Similar 
effects were observed with pregabalin treatment.(fig 33) 
FIG 33 ; Effect of vincristine induced histopathological changes. 
 
        a     b       c 
 
 
 
                                        d              e 
  
Parts a-e show transverse section of sciatic nerve of  normal, vincristine, IPC 
(200 and 300 mg/kg) and pregabalin treated groups. 
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DISCUSSION
[117-119] 
In this present study IPC extracts ameliorated vincristine induced behavioral 
(thermal hyperalgesia and cold chemical allodynia) and biochemical (TBARS,GSH 
and Total calcium) changes. After vincristine treatment the behavioral alterations 
started from day 3 and the maximal nociceptive threshold was observed on the 9
th
 
day. These observations are in line with reports from other laboratories. Vincristine 
has been widely used for the management of various cancer disorders including 
Hodgkin’s disease. However, its clinical application has been limited due to 
unavoidable painful neuropathy. It possess high binding affinity towards β-tubulin 
(neuronal cytoskeleton protein). Subsequently it has been documented to cause 
disruption of microtubule polymerization eventually leading to neurotoxicity as well 
as cancer preventive (Swain and Arezzo, 2008). Vincristine treatment in our study 
produced an increase   in the levels of calcium, TBARS and decrease in the level of 
GSH. However increase in ca
2+
 levels and free radical generation have also been 
implicated in pathogenesis of vincristine induced painful neuropathy.
[117-119]
 In the 
present study, vincristine treatment was noted to increase ca2+ levels as well as 
oxidative stress(indicated by elevated TBARS and decreased GSH level), supporting 
the contention that ca
2+
 and free radicals play a key role in development of vincristine 
induced neuropathy. Administration of IPC extract attenuated vincristine induced rise 
in calcium and TBARS   levels and increases GSH levels. The results of this study 
proved that the antinociceptive and antineuropathic pain activity of IPC may be due to 
its anti oxidant and calcium channel inhibitory activity. 
IPC has been reported for the presence of anti oxidant secondary metabolites 
like tannins and flavonoids. HPLC analysis of IPC revealed the presence of a 
flavonoid, kaempferol which has already been documented for antioxidant, 
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antinociceptive and anti-inflammatory activity. The present study also proved the anti 
inflammatory activity of IPC by in vitro membrane stabilization model. Hence anti 
neuropathic pain activity of IPC may be due to the presence kaempferol. 
IN VITRO MEMBRANE STABILIZATION STUDY 
The results obtained from the in vitro membrane stabilization study is 
presented in tab . 
This study revealed that IPC extract showed significant membrane 
stabilization activity (IC50 944.8 µg/mL) when compared with standard drug 
Diclofenac sodium(IC50 836.2 µg/mL). The result was presented in table 15.(fig 34) 
Table 15: Percentage of membrane stabilization by Diclofenac 
and  IPC  extract 
Con.c in 
µg/ml 
Percentage 
inhibition of 
Diclofenc 
Percentage inhibition of 
IPC extract 
200 26.3±0.30 23.7±1.90 
400 34.8±0.99 33.0±0.44 
600 39.8±0.11 36.8±0.56 
800 46.0±0.71 43.7±0.26 
1000 55.1±0.85 47.6±1.25 
IC50 836.2µg/Ml 944.82µg/mL 
*mean of three readings ± SEM 
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FIG 34:  Percentage of membrane stabilization by IPC extract 
 
Discussion 
[114-116] 
Lysosomes are intracellular particles which contain most of the lytic and 
digestive enzymes of the tissue. The rupture of the lysosomes results in injury or 
death to surrounding tissues and also acute inflammation. The membranes of 
lysosomes and erythrocytes are destroyed by similar agents; hence a test was 
developed to measure the ability of compounds to stabilize erythrocyte membrane to 
heat hemolysis. RBCs when exposed to various injurious substances such as methyl 
salicylate, phenyl hydrazine, and hypotonic medium or over heat will cause lysis of 
membrane accompanied by heamolysis and oxidation of hemoglobin. RBCs 
membranes are easily susceptible to free radical mediated lipid peroxidation by break 
down of biomolecules. RBCs membranes are similar to lysosomal cells. All NSAIDs 
inhibited hemolysis while other type of compounds had no effect. Hence prevention 
of hypotonic and heat mediated RBCs membrane lysis taken as measure of anti 
inflammatory activity of drugs. 
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A study has reported that the flavonoids exert membrane stabilizing effect on 
lysosomes both in-vitro and in vivo in experimental animals. Kaempferol has already 
been reported for anti-inflammatory activity. In the present study, HPLC evaluation of 
IPC extract revealed the presence of kaempferol. The results of the present study also 
indicate that the anti-inflammatory activity of IPC extract may be due to the presence 
of kaempferol.
[
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CHAPTER - VII 
SUMMARY AND CONCLUSION 
 Many unknown and lesser know plants are used in folk and tribal medical 
practice as a source of medicine. The medicinal values of these plants are not brought 
in to the lime light of scientific world. One such plant is Ipomoea pes-caprae. 
Keeping this in view an attempt was made to bring the lime light of the commonly 
occurring plant Ipomoea pes-caprae. 
 This dissertation work covers an extensive study on the leaves of Ipomoea 
pes-caprae also known as beach morning glory belongs to the family convolvulaceae. 
  The pharmacognostical, phytochemical profile including preliminary 
phytochemical screening, analysis and quantification of kaempferol in the plant 
extract by HPLC and pharmacological studies were carried out for the in vitro anti-
inflammatory activity and in vivo anti neuropathic pain activity in vincristine induced 
neuropathy model. 
 Pharmacognostical studies establishes macroscopical, microscopical and 
analytical standard and characterization of leaves of this plant. These evaluation can 
be used further as identification and standardization parameters of the leaves. 
 Preliminary phytochemical screening on the leaves of Ipomoea pes-caprae 
confirms the presence of tannins, flavonoids, sterols, carbohydrates and saponins. The 
quantification of total phenolic, flavonoid and tannin was determined for ethanolic 
extract of leaves of Ipomoea pes-caprae which were found to be 22.27 mg/g, 217.1 
mg/g and 157.259 mg/g respectively. It proves the significant concentration of these 
phytoconstituents in the ethanolic extract of Ipomoea pes-caprae. HPLC studies of 
IPC extract and standard   kaempferol revealed that the presence of kaempferol in this 
extract and the tR of standard and sample were found to be 5.87 mins and 5.88 mins 
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respectively.  Kaempferol content present in this extract was quantified as 0.034 %. 
So for kaempferol has not been reported from the leaves of this plant. This is the first 
time we have reported the presence of this compound from the leaves of this plant. 
IPC showed significant radical scavenging activity for Hydrogen peroxide, 
DPPH, Total antioxidant and reducing power assay. This may be due to the presence 
of flavonoid constituent like kaempferol. 
IPC extract exhibited significant anti inflammatory activity in the in vitro 
membrane stabilization model (IC50 944.8 µg/mL) when compared with standard 
drug Diclofenac sodium (IC50 836.2 µg/mL). 
Flavonoid has been reported for invitro anti-inflammatory activity. 
Kaempferol also has already been reported for anti-inflammatory activity. Hence the 
anti-inflammatory activity of IPC extract may be attributed due to the presence of 
kaempferol. 
IPC extract exhibited anti neuropathic pain activity against vincristine induced 
neuropathy model at the dose level of 200 mg and 300 mg/kg. This extract showed 
significant anti neuropathic pain activity by attenuating vincristine induced 
behavioral, biochemical and histopathological alterations in a dose dependent manner. 
This study also showed that antioxidant and calcium inhibitory potential was 
attributed for the anti neuropathic pain activity of IPC extract. Flavonoid  
phytoconstituents like kaempferol has been reported for anti oxidative, anti 
inflammatory, calcium inhibitory and antinociptive activity. Hence it was concluded 
that anti neuropathic pain activity of IPC extract may be due to the presence of 
kaempferol. 
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Future scope of the study 
Further studies are needed to isolate the active principles from IPC extract and 
the same may be evaluated for anti neuropathic pain and anti inflammatory activity 
using various animal models. The isolated active principles as well as the extract may 
be developed in a suitable formulation and they may be marketed after subjecting 
them for appropriate clinical trial studies. 
 This formulations prepared from this drug will be beneficial to the patients 
those who are suffering from neuropathy of various etiologies such as drug induced 
neuropathy, alcoholic neuropathy and diabetic neuropathy. The currently available 
anti neuropathic pain drugs such as pregabalin, gabapentin amitriptylline, duoloxetine, 
and sodium valproate produces so many adverse effects and they are also not 
adequate to treat neuropathy. 
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